The impact of preoperative EUS-FNA for distal resectable pancreatic cancer: Is it really effective enough to take risks?
Jin‐Seok Park(University of Southern California), Myung‐Hwan Kim(Korea Aerospace Research Institute), Ki Byung Song(Ulsan College), Dae Wook Hwang(Asan Medical Center), Sung Koo Lee(Ulsan College), Dong Wan Seo(Dankook University), Joune Seup Lee(Ulsan College), Song Cheol Kim(Ulsan College), Tae Jun Song, Jae Hoon Lee(Ulsan College), Sang Soo Lee(Chungbuk National University Hospital), Dongwook Oh(Ulsan College), Seok Jung Jo(Ulsan College), Do Hyun Park(Massachusetts Institute of Technology)
Cited by 15
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
TIMP-2 Mediated Inhibition of Angiogenesis
|Cell|2003|510
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299